Ticker Details
Krystal Biotech, Inc. Krystal Biotech Inc is a biopharmaceutical company. It uses gene therapy treatments for patients suffering from rare debilitating disorders.
IPO Date:	September 20, 2017
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$10.94B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$2.18 | 2.68%
Avg Daily Range (30 D):	$5.88 | 1.76%
Avg Daily Range (90 D):	$4.96 | 1.68%

Institutional Daily Volume
Avg Daily Volume:	.16M
Avg Daily Volume (30 D):	.24M
Avg Daily Volume (90 D):	.22M

Trade Size
Avg Trade Size (Sh.):	41
Avg Trade Size (Sh.) (30 D):	22
Avg Trade Size (Sh.) (90 D):	24

Institutional Trades
Total Institutional Trades:	2,377
Avg Institutional Trade:	$4.63M
Avg Institutional Trade (30 D):	$19.81M
Avg Institutional Trade (90 D):	$13.63M
Avg Institutional Trade Volume:	.03M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$5.92M
Avg Closing Trade (30 D):	$24.65M
Avg Closing Trade (90 D):	$15.94M
Avg Closing Volume:	41.86K

News

Jul 7, 2026 @ 11:15 PM 3 Soaring Stocks That May Have More Upside Ahead Source: Prosper Junior Bakiny

Jun 18, 2026 @ 5:30 AM These 3 Stocks Have Crushed the Market This Year. ... Source: Prosper Junior Bakiny

Apr 30, 2026 @ 12:00 PM Krystal Biotech to Present at Upcoming Scientific ... Source: Na

Apr 16, 2026 @ 7:26 PM Is Vertex Pharmaceuticals' Empire in Trouble? Source: Prosper Junior Bakiny

Mar 16, 2026 @ 8:00 PM What to Know About This Obesity Drug Developer Tha... Source: Jonathan Ponciano

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$7.75	$1.91	$1.77
Diluted EPS	$7.48	$1.83	$1.7
Revenue	$417.3M	$116.36M	$107.11M
Gross Profit
Net Income / Loss	$225.03M	$55.93M	$51.4M
Operating Income / Loss	$178.64M	$53.69M	$44.27M
Cost of Revenue
Net Cash Flow	$192.54M	$5.01M	$103.7M
PE Ratio